|
|
| | Indeloxazine hydrochloride Basic information |
| Product Name: | Indeloxazine hydrochloride | | Synonyms: | MORPHOLINE, 2-[(1H-INDEN-7-YLOXY)METHYL]-, HYDROCHLORIDE;Indeloxazine hydrochloride;CI 874;Elen;Noin;YM 08054;YM 08054-1;(±)-2-[(1H-Inden-7-yloxy)methyl]morpholine hydrochloride | | CAS: | 65043-22-3 | | MF: | C14H18ClNO2 | | MW: | 267.75 | | EINECS: | | | Product Categories: | | | Mol File: | 65043-22-3.mol |  |
| | Indeloxazine hydrochloride Chemical Properties |
| Melting point | 169-170°; mp 155-156° | | storage temp. | Sealed in dry,Room Temperature |
| RIDADR | 3249 | | HazardClass | 6.1(b) | | PackingGroup | III | | Toxicity | LD50 in mice (mg/kg): 47 i.v. (Tachikawa) |
| | Indeloxazine hydrochloride Usage And Synthesis |
| Description | Indeloxazine hydrochloride is a nootropic indicated for the treatment of senile dementia.
In animal models indeloxazine reportedly enhances brain energy metabolism and
monoamine content; its claimed protective effect on ischemia-induced amnesia is
supported by the prolonged step-through latency in passive avoidance tests. | | Originator | Yamanouchi (Japan) | | Uses | Antidepressant. | | Brand name | Elen | | Metabolic pathway | After oral administration of indeloxazine hydrochloride
to rats, two conjugates, which are labile to a-
glucosidase hydrolysis but refractory to b-glucosidase,
are isolated from the urine and identified as a-D-
glucopyranosides of trans-4-(2-morpholinylmethoxy)-
1,2-indandiol and trans-6-[[(1,2-dihydroxy-4-
indanyl)oxy]-methyl]-3-morpholinone. |
| | Indeloxazine hydrochloride Preparation Products And Raw materials |
|